Straightforward answers
with iPSC and phenotypic assays

Phenotypic assays with iPSC-derived cells help deciphering the full range of molecular mechanisms affected by a pathology.
Efficacy and toxicity assays become relevant to human diseases.

250 lead compounds screened from a million compounds enter pre-clinical testing

10 of them will proceed to clinical trial

1 will be approved by regulatory authorities

  • For one-third, pre-clinical investigations are performed in vitro.
  • Increasing the relevance of in vitro tools to the pathophysiological situation greatly improves drug screening efficacy and limits the occurrence of false-positive molecules
  • Our assays are designed to monitor crucial physiological functions, including: cell death, cell proliferation. DNA repair, axonal elongation and branching (Neural stem cells), and many more...

Shift from target-based to phenotypic assays with PhenoTest

A highly qualified team of researchers and engineers is here to help accelerating your R&D programs

Custom R&D

A dedicated and experienced team
to move your projects forward

Trusted iPSC expert

Partnering Research Organization
since 2013
100% of our clients recommend Phenocell*
Your trusted partner for personnalized iPSC-based R&D solutions
*Satisfaction survey performed on Dec 2019, on a representative sample of customers
Move your R&D forward
with our innnovative, efficient and cost-effective bioassays and products
Get in touch